- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 20.02. | Ultimovacs - Another ODD boosts the off-the-shelf, universal UV1 | 284 | Ultimovacs has been granted Orphan Drug designation (ODD) from the European Medicines Agency (EMA) for UV1 in mesothelioma, marking another step forward for the clinical development of its lead universal... ► Artikel lesen | ||
| 19.02. | Dunelm Group - Appealing offer | 252 | Dunelm Group's (DNLM's) H124 results demonstrated the benefits of its strategy of broadening its addressable market by strengthening the core offer and expanding into newer categories, while also growing... ► Artikel lesen | ||
| 19.02. | Sareum Holdings - Positive clinical step forward in SDC-1801 | 237 | Sareum Holdings has announced positive clinical progression for SDC-1801, its lead asset and novel TYK2/JAK1 inhibitor targeting the autoimmune space (with an initial focus on psoriasis). Preliminary... ► Artikel lesen | ||
| 19.02. | Phoenix Spree Deutschland - One city but two tales | 180 | Phoenix Spree Deutschland's (PSD's) trading update contrasts the strength of the Berlin private rental sector, reflected in PSD's increased rents and low occupancy, with the subdued investment market... ► Artikel lesen | ||
| 19.02. | AFT Pharmaceuticals - US milestone triggers upside and guidance bump | 287 | AFT Pharmaceuticals has announced the first sale of its intravenous pain relief medicine, Maxigesic IV, through its US licensing partner, Hikma Pharmaceuticals, a material milestone for AFT's portfolio... ► Artikel lesen | ||
| 16.02. | Ultimovacs - Universal approach with critical readouts in March | 240 | Ultimovacs recapped an active FY23 period for its universal cancer vaccine, UV1, including the reported benefit in overall survival and desirable safety profile from the NIPU trial in malignant pleural... ► Artikel lesen | ||
| 15.02. | Arctic Paper - Resilient FY23 masked by record comparator | 363 | FY23 was a year with numerous obstacles for the European paper and pulp industry, including lower demand due to an economic downturn and customer destocking. Nevertheless, Arctic Paper's performance... ► Artikel lesen | ||
| 15.02. | Mendus - Potential disruptor to AML maintenance setting | 309 | Mendus has reported FY23 results, summarising an active period. For its lead asset, vididencel, long-term survival data from the ADVANCE II trial reinforce the drug's potential as maintenance therapy... ► Artikel lesen | ||
| 15.02. | Finsbury Growth & Income Trust - Looking forward to improved relative performance | 319 | Finsbury Growth & Income Trust (FGT) has been managed by Nick Train since the beginning of 2001 and in 2019 Madeline Wright was appointed as the trust's deputy portfolio manager. Despite an impressive... ► Artikel lesen | ||
| 15.02. | Checkit - FY24 revenue and ARR in line, EBITDA ahead | 215 | Checkit's FY24 trading update confirmed that revenue and year-end annual recurring revenue (ARR) were in line with our forecasts, up 17% and 16% respectively. Better cost control resulted in a smaller... ► Artikel lesen | ||
| 14.02. | Revolution Beauty Group - Looking good | 397 | Revolution Beauty Group's (REVB's) capital markets day (CMD) provided an opportunity for the new management team to present its refocused strategy: to become a top five global beauty brand by 2030.... ► Artikel lesen | ||
| 14.02. | The Diverse Income Trust - Manager anticipates a small-cap super cycle | 160 | The Diverse Income Trust's (DIVI's) managers Gervais Williams and Martin Turner focus on generating a dividend income stream that is more resilient and has the potential to grow faster than those of... ► Artikel lesen | ||
| 13.02. | KEFI Gold and Copper - Counting down to launch in H124 | 434 | In its post-Indaba release of 13 February, KEFI announced that the multi-party, subsidiary-level financing of its Tulu Kapi gold project in Ethiopia is now advancing on the back of Ethiopian federal... ► Artikel lesen | ||
| 12.02. | Custodian Property Income REIT - On track to meet dividend target | 239 | Custodian Property Income REIT (CREI) has released a trading update for the three months to 31 December 2023 (Q424). The quarterly DPS was fully covered by unaudited EPRA earnings and was in line with... ► Artikel lesen | ||
| 12.02. | Avon Protection - Unmasking its growth potential | 254 | Avon Protection's capital markets day highlighted its continued focus on medium-term margin expansion (targeting operating margin of 14-16%), concentrating on its core business of respirators and head... ► Artikel lesen | ||
| 12.02. | GCP Infrastructure Investments - Key takeaways from capital markets day | 264 | GCP Infrastructure Investments (GCP) has a mature, diverse and operational portfolio of 51 UK infrastructure assets with a total asset value of £1.1bn and a net asset value (NAV) of £953m, two-thirds... ► Artikel lesen | ||
| 12.02. | Claranova - Guiding to strong H124 EBITDA growth | 379 | Claranova reported a small increase in H124 revenue on a constant currency (cc) basis, as good growth in Avanquest and myDevices offset lower revenue in the larger PlanetArt division. Management expects... ► Artikel lesen | ||
| 12.02. | IRLAB Therapeutics - Timeline refresh with numerous inflection points | 247 | IRLAB has reported FY23 results and provided operational and regulatory updates, including an end-of-Phase II (EoP2) meeting with the FDA for mesdopetam and extended patent protection for pirepemat... ► Artikel lesen | ||
| 12.02. | Immix Biopharma - Updates galore: NXC-201 ODD (EU) and raise | 252 | Immix Biopharma has released back-to-back updates, including EU orphan drug designation (ODD) for its lead CAR-T asset NXC-201, addressing amyloid light chain amyloidosis (ALA), and pricing of its $15m... ► Artikel lesen | ||
| 09.02. | Cordel Group - Railtech play with scalable potential | 271 | Cordel Group is a UK technology company that provides an end-to-end data management platform for automated rail infrastructure monitoring. At its core, the company transforms fragmented legacy datasets... ► Artikel lesen | ||
| 08.02. | Creo Medical - Solid FY23 lays the groundwork for 2024 | 244 | Creo Medical has released a trading update for FY23, an active year for the company, with progress made across all business segments. Traction improved in H223, following Speedboat Inject's European... ► Artikel lesen | ||
| 08.02. | Babcock International Group - Steadfast defence | 356 | Babcock's capital markets day reaffirmed its transformation over the past two years, facilitated by a series of disposals and a focus on core defence expertise (69% of H124 revenue). It is well positioned... ► Artikel lesen | ||
| 08.02. | Nanoco - Steps on the pathway to volume production | 169 | Nanoco's trading update confirms that H124 revenues and EBITDA are anticipated to be in line with company expectations. The main new information is that the company has commenced the build and fitout... ► Artikel lesen | ||
| 08.02. | Intralot Integrated Lottery Systems and Services - In it to win it | 243 | Intralot Integrated Lottery Systems and Services (Intralot) is a leading developer and supplier of integrated gaming systems and services that cover the entire value chain of select gaming markets.... ► Artikel lesen | ||
| 08.02. | VolitionRx - Snaring sepsis, with early NETs detection | 388 | VolitionRx continues to make headway in growing a body of clinical evidence to build Nu.Q® NETs as a potential breakthrough tool in sepsis. These efforts, coupled with its CE mark in Europe, are a strong... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
